These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8478553)

  • 21. Pure sensory Guillain-Barré syndrome.
    Miralles F; Montero J; Reñe R; Martinez Matos JA
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):411-2. PubMed ID: 1602318
    [No Abstract]   [Full Text] [Related]  

  • 22. An approach to the care of patients with Guillain-Barré syndrome.
    Griswold K; Guanci MM; Ropper AH
    Heart Lung; 1984 Jan; 13(1):66-72. PubMed ID: 6559188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.
    Griffin JW; Li CY; Macko C; Ho TW; Hsieh ST; Xue P; Wang FA; Cornblath DR; McKhann GM; Asbury AK
    J Neurocytol; 1996 Jan; 25(1):33-51. PubMed ID: 8852937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barré syndrome: MR imaging findings of the spine in eight patients.
    Byun WM; Park WK; Park BH; Ahn SH; Hwang MS; Chang JC
    Radiology; 1998 Jul; 208(1):137-41. PubMed ID: 9646804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.
    Yako K; Kusunoki S; Kanazawa I
    J Neurol Sci; 1999 Oct; 168(2):85-9. PubMed ID: 10526188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.
    Kanda T; Hayashi H; Tanabe H; Tsubaki T; Oda M
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):857-64. PubMed ID: 2769280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome: clinical neurophysiologic studies.
    Cros D; Triggs WJ
    Rev Neurol (Paris); 1996 May; 152(5):339-43. PubMed ID: 8881426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and severity of conduction abnormalities in Guillain-Barré syndrome.
    Brown WF; Snow R
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):768-74. PubMed ID: 1659615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic neuropathies: new aspects of Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, an overview and an update.
    Trojaborg W
    Electroencephalogr Clin Neurophysiol; 1998 Nov; 107(5):303-16. PubMed ID: 9872432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.
    Vriesendorp FJ; Triggs WJ; Mayer RF; Koski CL
    J Neurol; 1995 Jul; 242(7):460-5. PubMed ID: 7595678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré syndrome.
    Koski CL
    Neurol Clin; 1984 May; 2(2):355-66. PubMed ID: 6334227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve conduction in the Guillain-Barré-Strohl syndrome.
    Hausmanowa-Petrusewicz I; Emeryk B; Rowińska-Marcińska K; Jedrzejowska H
    J Neurol; 1979 May; 220(3):169-84. PubMed ID: 88509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Guillain-Barré syndrome.
    Van der Meché FG
    Baillieres Clin Neurol; 1994 Apr; 3(1):73-94. PubMed ID: 7921592
    [No Abstract]   [Full Text] [Related]  

  • 37. Inflammatory-demyelinating polyneuropathies.
    Feasby TE
    Neurol Clin; 1992 Aug; 10(3):651-70. PubMed ID: 1323748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration.
    Triggs WJ; Cros D; Gominak SC; Zuniga G; Beric A; Shahani BT; Ropper AH; Roongta SM
    Brain; 1992 Oct; 115 ( Pt 5)():1291-302. PubMed ID: 1422789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome associated with Hashimoto's thyroiditis.
    Behar R; Penny R; Powell HC
    J Neurol; 1986 Aug; 233(4):233-6. PubMed ID: 3755753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal serum factors in Guillain-Barré syndrome.
    Lisak RP; Brown MJ; Summer AJ
    Ital J Neurol Sci; 1983 Sep; 4(3):265-72. PubMed ID: 6358121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.